{"title":"男性生化复发和转移性前列腺癌的睾酮治疗:初步观察","authors":"A. Morgentaler, A. Abello, G. Bubley","doi":"10.1089/ANDRO.2021.0001","DOIUrl":null,"url":null,"abstract":"Introduction: Although prostate cancer (PCa) has long been considered an absolute contraindication for testosterone therapy (TTh), growing literature suggests TTh may be safely offered to men with ...","PeriodicalId":72197,"journal":{"name":"Androgens: clinical research and therapeutics","volume":"3 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":"{\"title\":\"Testosterone Therapy in Men with Biochemical Recurrence and Metastatic Prostate Cancer: Initial Observations\",\"authors\":\"A. Morgentaler, A. Abello, G. Bubley\",\"doi\":\"10.1089/ANDRO.2021.0001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Although prostate cancer (PCa) has long been considered an absolute contraindication for testosterone therapy (TTh), growing literature suggests TTh may be safely offered to men with ...\",\"PeriodicalId\":72197,\"journal\":{\"name\":\"Androgens: clinical research and therapeutics\",\"volume\":\"3 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Androgens: clinical research and therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/ANDRO.2021.0001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Androgens: clinical research and therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/ANDRO.2021.0001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Testosterone Therapy in Men with Biochemical Recurrence and Metastatic Prostate Cancer: Initial Observations
Introduction: Although prostate cancer (PCa) has long been considered an absolute contraindication for testosterone therapy (TTh), growing literature suggests TTh may be safely offered to men with ...
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
